Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  PPD, Inc.    PPD

PPD, INC.

(PPD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/19/2020 11/20/2020 11/23/2020 11/24/2020 11/25/2020 Date
33.69(c) 33.75(c) 33.88(c) 33.79(c) 33.7(c) Last
1 173 620 664 756 889 146 1 095 400 928 635 Volume
-0.44% +0.18% +0.39% -0.27% -0.27% Change
More quotes
Financials (USD)
Sales 2020 4 601 M - -
Net income 2020 140 M - -
Net Debt 2020 3 432 M - -
P/E ratio 2020 84,2x
Yield 2020 -
Sales 2021 5 062 M - -
Net income 2021 368 M - -
Net Debt 2021 2 956 M - -
P/E ratio 2021 33,4x
Yield 2021 0,04%
Capitalization 11 815 M 11 815 M -
EV / Sales 2020 3,31x
EV / Sales 2021 2,92x
Nbr of Employees 23 000
Free-Float 61,2%
More Financials
Company
PPD, Inc. provides drug development services to the biopharmaceutical industry. The Company provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, as well as other industry participants. The Company’s business segments include Clinical Development Services segment and Laboratory Services segment. Its Clinical Development Services... 
More about the company
Notations Surperformance© of PPD, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about PPD, INC.
11/18MODERNA : Announces Supply Agreement with United Kingdom Government to Supply mR..
AQ
11/02PPD : Named Clinical Research Company of the Year
BU
10/28PPD : Management's Discussion and Analysis of Financial Condition and Results of..
AQ
10/27PPD, INC. : Results of Operations and Financial Condition, Financial Statements ..
AQ
10/27PPD : Reports Third Quarter and Year to Date 2020 Results
BU
10/26PPD : Accelerated Enrollment Solutions Wins SCRS Site Tank Award
BU
10/23MODERNA : Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine against COV..
AQ
10/15Morgan Stanley profit crushes estimates on trading strength
RE
10/13PPD : to Open Multipurpose Clinical Research Laboratory in Suzhou, China
BU
10/12PPD : Announces Third Quarter 2020 Earnings Conference Call
BU
10/06PPD : Recognized at Vaccine Industry Excellence Awards
BU
09/30PPD ACHIEVES ISO/IEC 27001 : 2013 Certification for Information Security Managem..
BU
09/17PPD : Named a Top 50 Employer in Bulgaria
BU
09/17PPD, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/16PPD : Announces Pricing of Secondary Offering of Shares of Common Stock
BU
More news
News in other languages on PPD, INC.
07/27LA VALEUR DU JOUR À WALL STREET MODE : dernière étape avant le lancement de son ..
03/26Trotz Corona weltweit mehr Börsengänge zu Jahresbeginn
02/28PPD, INC. : Veröffentlichung des Jahresergebnisses
02/28PPD, INC. : publication des résultats annuels
More news
Chart PPD, INC.
Duration : Period :
PPD, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PPD, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Average target price 39,30 $
Last Close Price 33,79 $
Spread / Highest target 24,3%
Spread / Average Target 16,3%
Spread / Lowest Target -6,78%
EPS Revisions
Managers
NameTitle
David S. Simmons Chairman & Chief Executive Officer
William Jacob Sharbaugh Chief Operating Officer
Christopher G. Scully CFO, Treasurer, Executive VP & Assistant Secretary
David Johnston Executive VP-Global Clinical Development
Karen Kaucic Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
PPD, INC.0.00%11 815
LONZA GROUP AG56.17%44 950
MODERNA, INC.403.89%39 001
CELLTRION, INC.82.32%36 284
IQVIA HOLDINGS INC.11.32%32 977
SEAGEN INC.44.08%29 684